Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,514 | 14,280 | 21,511 | 30,268 | 22,116 |
| TOTAL | $8,104 | $15,103 | $22,433 | $31,474 | $23,552 |
| Non-Current Assets | |||||
| PPE Net | 681 | 748 | 817 | 886 | 932 |
| Other Non-Current Assets | 8,344 | 8,633 | 8,914 | 9,128 | 9,352 |
| TOTAL | $9,025 | $9,381 | $9,731 | $10,014 | $10,284 |
| Total Assets | $17,129 | $24,484 | $32,164 | $41,488 | $33,836 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 922 | 4,716 | 6,413 | 8,863 | 10,284 |
| Accrued Expenses | 1,456 | 1,322 | 5,703 | 4,488 | 2,861 |
| TOTAL | $3,525 | $7,141 | $13,177 | $14,220 | $13,973 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,258 | 7,560 | 7,854 | 8,142 | 8,406 |
| TOTAL | $7,258 | $7,560 | $7,854 | $8,142 | $8,406 |
| Total Liabilities | $10,783 | $14,701 | $21,031 | $22,362 | $22,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,440 | 4,440 | 3,682 | 3,498 | 3,356 |
| Common Shares | 4 | 4 | 4 | 3 | 27 |
| Retained earnings | -229,347 | -225,836 | -217,966 | -207,106 | -193,293 |
| TOTAL | $6,346 | $9,783 | $11,133 | $19,126 | $11,457 |
| Total Liabilities And Equity | $17,129 | $24,484 | $32,164 | $41,488 | $33,836 |